Roche Joins Massachusetts Program to Support Early Stage LS Companies | GenomeWeb

NEW YORK (GenomeWeb) – The Massachusetts Life Sciences Center today said that Roche has joined the Center's Corporate Consortium Partners to support early stage life science firms in the state.

As a member, Roche will provide funding to support MLSC's investments in such businesses, and in return, Roche will have access to new technologies that may potentially lead to new healthcare solutions, MLSC said. According to an MLSC spokesperson, Roche will provide $250,000 to the consortium partner program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?